The enigmatic neutrophil: what we do not know

被引:0
|
作者
Paul Kubes
机构
[1] University of Calgary,Departments of Physiology and Pharmacology, Microbiology and Immunology and Critical Care Medicine, Snyder Institute for Chronic Disease
来源
Cell and Tissue Research | 2018年 / 371卷
关键词
Neutrophil killing mechanisms; Inflammation; Healing; Imaging; Neutrophil extracellular traps aggregates;
D O I
暂无
中图分类号
学科分类号
摘要
The neutrophil appears to be undergoing a renaissance of sorts. While it was for many years thought to be a killing machine brought into tissues to eradicate pathogens, it is now being implicated in many other processes, ranging from acute injury and repair, chronic inflammatory processes, cancer and auto-immunity. Not only is it an effector of the innate immune response, it appears to also potentially contribute to adaptive immunity, implicated in either contributing to the development of specific adaptive immune responses or perhaps even instructing and directing certain adaptive immune responses. With this renewed interest in the neutrophil and its numerous new functions, it is worth examining not what we know but rather what we do not know and what still needs to be more thoroughly examined. In this review, consideration is given to such topics as neutrophil subtypes, neutrophil differentiation, neutrophil as a director of immunity, neutrophil residency and ultimately death of the neutrophil.
引用
收藏
页码:399 / 406
页数:7
相关论文
共 50 条
  • [1] The enigmatic neutrophil: what we do not know
    Kubes, Paul
    CELL AND TISSUE RESEARCH, 2018, 371 (03) : 399 - 406
  • [2] Aging - What Do We Know?
    Bergler-Czop, Beata
    Miziolek, Bartosz
    ACTA DERMATOVENEROLOGICA CROATICA, 2017, 25 (01) : 50 - 56
  • [3] Cardiac Imaging in the Geriatric Population: What Do We Think We Know, and What Do We Need to Learn?
    Mehta, Nidhi
    Chokshi, Neel P.
    Kirkpatrick, James N.
    PROGRESS IN CARDIOVASCULAR DISEASES, 2014, 57 (02) : 204 - 214
  • [4] Interstitial lung abnormalities: What do we know and how do we manage?
    Liu, Qi
    Zhang, Hai
    Han, Baohui
    Jiang, Handong
    Chung, Kian Fan
    Li, Feng
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2021, 15 (12) : 1551 - 1561
  • [5] NETosis and kidney disease: what do we know?
    Demet Alaygut
    Ilyas Ozturk
    Sena Ulu
    Ozkan Gungor
    International Urology and Nephrology, 2023, 55 : 1985 - 1994
  • [6] What do we know about the inflammasome in humans?
    Amin, Jay
    Boche, Delphine
    Rakic, Sonja
    BRAIN PATHOLOGY, 2017, 27 (02) : 192 - 204
  • [7] Benign prostatic hyperplasia - what do we know?
    Devlin, Conor M.
    Simms, Matthew S.
    Maitland, Norman J.
    BJU INTERNATIONAL, 2021, 127 (04) : 389 - 399
  • [8] NETosis and kidney disease: what do we know?
    Alaygut, Demet
    Ozturk, Ilyas
    Ulu, Sena
    Gungor, Ozkan
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2023, 55 (08) : 1985 - 1994
  • [9] Periodontitis and Rheumatoid Arthritis: What Do We Know?
    de Smit, Menke J.
    Westra, Johanna
    Brouwer, Elisabeth
    Janssen, Koen M. J.
    Vissink, Arjan
    van Winkelhoff, Arie Jan
    JOURNAL OF PERIODONTOLOGY, 2015, 86 (09) : 1013 - 1019
  • [10] Management of lung disease in alpha-1 antitrypsin deficiency: what we do and what we do not know
    Barjaktarevic, Igor
    Campos, Michael
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2021, 12